Skip to main navigation
CareDx
  • COMPANY
    • Management Team
    • Board of Directors
    • Compliance
    • Careers
      • Current Openings
      • Benefits
  • PRODUCTS
    • HeartCare, AlloMap
    • KidneyCare, AlloSure
    • Laboratory Products
    • Ottr
  • INVESTORS
  • CONTACT US

Press Releases

Media Inquiries - media@caredxinc.com
Date Title and Summary Additional Formats
Toggle Summary Oct 07, 2020 CareDx Reports Preliminary Third Quarter 2020 Revenue
SOUTH SAN FRANCISCO, Calif. , Oct. 07, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today
View HTML
Toggle Summary Oct 02, 2020 CareDx Announces Publication of Pivotal AlloSure Lung Data
LARGO and The University of Texas Health Science Center at San Antonio publications demonstrate benefits of AlloSure in lung transplant patients SOUTH SAN FRANCISCO, Calif. , Oct. 02, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the
View HTML
Toggle Summary Oct 01, 2020 CareDx Receives Final Medicare Coverage Decision for AlloSure Heart
Final decision on AlloSure Heart paves the way for HeartCare, the most comprehensive multi-modality tool available to heart transplant patients SOUTH SAN FRANCISCO, Calif. , Oct. 01, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the
View HTML
Toggle Summary Sep 24, 2020 CareDx Launches AlloCare at Virtual Transplant Festival
AlloCare mobile app is now available to help transplant patients manage their health, communicate efficiently, and stay connected SOUTH SAN FRANCISCO, Calif. , Sept. 24, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery,
View HTML
Toggle Summary Sep 11, 2020 CareDx Shares Latest Clinical Data at the TTS 2020 Virtual Conference
AlloSure and AlloSeq cfDNA surveillance tools to be featured along with four virtual symposia at international congress SOUTH SAN FRANCISCO, Calif. , Sept. 11, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and
View HTML
Toggle Summary Sep 10, 2020 CareDx Strengthens Leadership Team to Accelerate Growth
CareDx appoints key hires in digital services, laboratory operations, business development and market access SOUTH SAN FRANCISCO, Calif. , Sept. 10, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and
View HTML
Toggle Summary Sep 02, 2020 CareDx to Participate at Upcoming Conferences
SOUTH SAN FRANCISCO, Calif. , Sept. 02, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers,
View HTML
Toggle Summary Aug 04, 2020 CareDx Reports Second Quarter 2020 Results
Patient-focused during COVID-19 pandemic and succeeding SOUTH SAN FRANCISCO, Calif. , Aug. 04, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare
View HTML
Toggle Summary Jul 30, 2020 CareDx to Participate at the Canaccord Genuity 40th Annual Growth Conference
SOUTH SAN FRANCISCO, Calif. , July 30, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers,
View HTML
Toggle Summary Jul 16, 2020 CareDx to Report Second Quarter 2020 Financial Results
SOUTH SAN FRANCISCO, Calif. , July 16, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today
View HTML

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • …
  • Next page Next
  • Last page Last
Displaying 21 - 30 of 285 results

Investor Relations

  • Investor Relations
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Analyst Coverage
  • Investor FAQs
  • Contact Us

Shareholder Tools

Printed Materials
E-mail Alerts
Downloads
RSS
Print
Share
  • Facebook
  • LinkedIn
  • Twitter
  • RSS

    ©2004-2017 CareDx, Inc. All Rights Reserved.    CareDx is a registered trademark of CareDx, Inc.

    Privacy & Compliance